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Abstract
Propionibacterium avidum is a common inhabitant of sebaceous glands, traditionally considered to be of low virulence and
generally found on implanted foreign material. We report a rare case of P. avidum breast abscess, causing severe morbidity
following breast reduction surgery. A 36-year-old woman presented with a non-painful wound discharge 3 weeks
postoperatively, and was treated conservatively. She was readmitted 7 weeks postoperatively with a red and tender breast.
A purulent discharging abscesswas drained under ultrasound guidance. A 2-week intravenous course of amoxicillin–clavulanic
acid, followed by oral replacement for a month resulted effective. Serial ultrasound imaging was useful in treatment decision-
making. The infective potential of P. avidummay be underappreciated. Proximity of sutures to the axilla, tobacco smoking and
the potential for resorbable sutures to host bacteria may predispose to infection, and should raise the clinician’s awareness.
INTRODUCTION
Reduction mammoplasty is a common surgical procedure for
symptomatic breast hypertrophy. Postoperative complications
include haematoma, infection, fat necrosis and delayed wound
healing. Among infection agents, Staphylococcus aureus is the
most common primary infective organism. Propionibacterium avi-
dum [1–4] (P. avidum), a common inhabitant of sebaceous glands,
is traditionally considered to be of lowvirulence.We report one of
a few cases of P. avidum in breast tissue, and to our knowledge, the
third described following breast reduction. We recommend an
effective treatment for similar cases, drawing from the conclu-
sions of previous literature and our own experience.
CASE REPORT
A 36-year-old Caucasian heavy smoker (1 pack/day), with no
other comorbidities, presentedwith bilateral symptomatic breast
hypertrophy. Reduction mammoplasty was performed following
Thorek’s technique [5]. Standard disinfection was performed
with antiseptic povidone–iodine and 600 mg of intravenous (IV)
clindamycin was delivered at anaesthesia induction. More than
1.1 kg of tissuewas retrieved from each breast. Threeweeks post-
operatively, wound dehiscence associated with discharge was
noted on the inferior border of the right breast. Neither redness
nor heat was detected locally. The patient was apyrexial with
no inﬂammatory syndrome (WBC count 11 g/l and C-reactive
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protein 6 mg/l). A smear of the discharge with liponecrosis
showed low quantities of P. avidum. No antibiotic therapy was
introduced at this moment and dressings with argentic sulfadia-
zinewere prescribed every 48 h (Ialugen-plus, IBSA, Switzerland).
Seven weeks postoperatively, a new red and tender induration in
between the inferior quadrants of the right breast was noted.
Interestingly, the patient remained apyrexial with no inﬂamma-
tory syndrome. A breast ultrasound (US) showed a 4 × 4 × 15 cm
encapsulated collection (Fig. 1). The abscess was drained and
bacteriological examination of the purulent ﬂuid revealed a
larger quantity of P. avidum. Amoxicillin–clavulanic acid three
times/day IVwas started as empirical treatment for soft tissue in-
fection. During the IV antibiotic treatment, no differences were
seen in blood test parameters; however, a clinical improvement
was evident with the discharge steadily decreasing. A control
breast US on Day 5 post IV treatment showed remission of the
abscess (Fig. 2). Results of antibiogram analysis conﬁrmed the
bacteria presence and its sensitiveness to amoxicillin–clavulanic
acid. IV antibiotherapy was continued cessation of wound
dehiscence (2 weeks), and then switched to oral amoxicillin for
1 month (750 mg three times a day). A breast US 1 month later
showed abscess resolution and antibiotic therapy was discontin-
ued. On physical examination, the infection had healed, and no
surgical reintervention was needed (Fig. 3).
DISCUSSION
Propionibacteria are anaerobic, gram-positive bacilli and are a
genus of Coryneform bacteria. The incubation period of Propionibac-
teria infections can last from a few days to severalmonths [6]. Our
case is consistent with previous reports that have described the
insidious nature of infections with P. avidum following surgery
[4]. This organism is a usual inhabitant of sebaceous glands,
and hair follicles in the groin, perineal and axillary regions. The
slow growth of P. avidum and its commensal role as a skin organ-
ismmeans the infections canmore easily be overlooked. Typical-
ly, P. avidum is encountered in the presence of implanted foreign
material, which is an ideal terrain for bacterial adherence and
bioﬁlm formation [6]. Other described predisposing factors con-
tributing to P. avidum infections include immunosuppression,
trauma, malignancy, diabetes and obstruction of sinuses or
ducts [6]. Tobacco smoking in our case is likely to have increased
the pathogen’s morbidity postoperatively, severely affecting
wound healing and supporting liponecrosis. Even if we could
consider breast reduction surgery as a ‘clean procedure’, scar
proximity to the axilla needs to be included among contamin-
ation risks. In the few described cases of P. avidum infections
after breast reduction surgery, several antibiotic treatments
have been used (Table 1). Our antibiogram was consistent with
previous reports showing P. avidum to be sensitive to most anti-
biotics including penicillins, but not tometronidazole [4, 6]. Brief-
ly, the initial choice was to administer beta-lactamase-resistant
penicillins IV, followed by an oral replacement for up to 1
month. For possible penicillin allergies [2], an IV carbapenem
(meropenem) was used prior to an oral ﬂuoroquinolone (moxi-
ﬂoaxacin). Propionibacterium avidum is likely to be found in the
presence of implanted foreign materials. It produces an exopoly-
saccharide-like meshwork that has been hypothesized to play a
role in bioﬁlm formation [7], leading to persistent infections
that cannot be cleared by the immune system.While no prosthet-
ic material is present in reduction mammoplasty, sutures may
host bacteria during their resorption phase, which can last over
70 days.Moreover, the contamination can proceed through the ﬁ-
laments and cause inﬂammation in the surrounding tissue [8]. In
our case, braided resorbable sutures (Vycril™, Ethicon, Johnson&
Johnson, USA) were used for deep layers, followed by resorbable
monoﬁlaments for the dermis and skin (Monosyn®, B. Braun
Medical, Germany) [9, 10]. There is still debate whether braided
Figure 1: Right breast ultrasonography (US) showing encapsulated purulent
collection (4 × 4 × 15 cm) in correspondence of the lower lateral quadrant, 7
weeks after breast reduction surgery. Abscess drainage was performed under
US guidance.
Figure 2: Clinical status after US-guided drainage and 2 weeks IV antibiotic
therapy.
Figure 3: Complete wound healing after 6 weeks of antibiotic treatment and local
dressings.
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or monoﬁlament resorbable sutures should be used in con-
taminated surgical ﬁelds [9], with some human and in vivo
studies showing greater infection rates in polyﬁlament than
in monoﬁlament sutures, although other studies suggest no
difference [8, 10].
Our case provides evidence that P. avidum infections are not ex-
clusive to hardware material or contaminated prosthesis, but can
be encountered in breast reduction surgery, suggesting the poten-
tial bioﬁlm formation on sutures. Propionibacterium avidum gives
less striking clinical features when compared with other more
common pathogens, and may rest underappreciated. Despite the
low virulence of the pathogen, it can ﬁnally lead to severe morbid-
ity. In breast reduction with long inframammary scars, and in the
presence of predisposing factors such as smoking, diabetes or im-
munosuppression, P. avidum contaminationmaynot remain silent.
In such cases, the clinician’s suspicion should be raised. According
to our experience and given the previously reported cases, we sug-
gest an initial IV treatment with amoxicillin–clavulanic acid until
the cessation ofwounddischarge, followed bya 4-weekoral course
(oruntil completewoundhealing).AnUS shouldbe consideredasa
non-invasive and practical way to follow clinical evolution during
antibiotic treatment and on an outpatient basis.
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Table 1: Antibiotic treatments for P. avidum infection following breast reduction surgery in the literature
Surgery Treatment Time to complete
healing
Penicillin allergy Source
Bilateral breast reduction–
unilateral infection
IVAC for 2 weeks + 4 weeks oral AC 6 weeks Recalled possible allergy Reported case
Bilateral breast reduction and
infection
IV ﬂucloxacillin and benzyl penicillin
for 5 days + 4 weeks oral AC
5 weeks No Panagea et al. [1]
Bilateral breast reduction and
infection
IV meropenem+ 4 weeks oral
moxiﬂoxacin + 4 weeks oral AC
12 weeks Recalled possible allergy Levin et al. [2]
Unilateral mastectomy + TRAM
ﬂap reconstruction
IV ﬂucloxacillin + penicillin n/a No Werno et al. [4]
AC, amoxicillin–clavulanic acid; IV, intravenous; TRAM, transverse rectus abdomini muscle.
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